[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

[@DermTimesNow](/creator/twitter/DermTimesNow)
"📖 A new meta-analysis confirms #abrocitinib significantly improves itch and lesion severity in moderate to severe atopic dermatitis with a dose-dependent response and manageable safety profile. #DermTwitter #AD #AtopicDerm"  
![@DermTimesNow Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::55642575.png) [@DermTimesNow](/creator/x/DermTimesNow) on [X](/post/tweet/1947014682063053309) 2025-07-20 19:24:08 UTC 31.8K followers, XXX engagements


"📰 The stories of X #melanoma survivors featured in Dermatology Times' Derm Dispatch series highlight the critical importance of early detection routine exams and better education to catch skin cancer before it turns deadly. #SkinCancer #DermTwitter"  
![@DermTimesNow Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::55642575.png) [@DermTimesNow](/creator/x/DermTimesNow) on [X](/post/tweet/1945891745532637357) 2025-07-17 17:01:59 UTC 31.8K followers, XXX engagements


"👥🏛 A poster presented at #SDPA2025 highlighted the effectiveness of dupilumab (Dupixent; Regeneron Pharmaceuticals and Sanofi) in provided sustained long-term flare control in adult patients with moderate to severe atopic dermatitis"  
![@DermTimesNow Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::55642575.png) [@DermTimesNow](/creator/x/DermTimesNow) on [X](/post/tweet/1938953142680297693) 2025-06-28 13:30:27 UTC 31.8K followers, XXX engagements


"🌟🗓 Explore the top X articles from Dermatology Times from the past week including insights on the latest clinical trials therapeutic updates and more. #Top5 #DermTwitter"  
![@DermTimesNow Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::55642575.png) [@DermTimesNow](/creator/x/DermTimesNow) on [X](/post/tweet/1947417045227766228) 2025-07-21 22:02:59 UTC 31.8K followers, XXX engagements


"📚 A recent pilot study explored tildrakizumab an IL-23 inhibitor as a treatment for stable non-segmental vitiligo finding it safe but not significantly effective in promoting repigmentation over XX weeks"  
![@DermTimesNow Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::55642575.png) [@DermTimesNow](/creator/x/DermTimesNow) on [X](/post/tweet/1944864532146319694) 2025-07-14 21:00:12 UTC 31.8K followers, XXX engagements


"🔓🔑✨In an exclusive midyear review Dermatology Times highlights major FDA milestones that shaped the first half of 2025 reflecting significant momentum in the dermatologic pipeline"  
![@DermTimesNow Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::55642575.png) [@DermTimesNow](/creator/x/DermTimesNow) on [X](/post/tweet/1945106298623701047) 2025-07-15 13:00:54 UTC 31.8K followers, XXX engagements


"Dermatology Times and the rest of the community are mourning the sudden loss of Robert Sidbury MD MPH a visionary leader in pediatric dermatology whose impact and mentorship resonate deeply. Click here for more tributes from mentees and friends:"  
![@DermTimesNow Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::55642575.png) [@DermTimesNow](/creator/x/DermTimesNow) on [X](/post/tweet/1947674451048386910) 2025-07-22 15:05:49 UTC 31.8K followers, XXX engagements


"📚 A study of X million #MDhair app users reveals key hair loss trends as age genetics hormones stress and COVID-19 all impact #alopecia severity. #DermTwitter"  
![@DermTimesNow Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::55642575.png) [@DermTimesNow](/creator/x/DermTimesNow) on [X](/post/tweet/1946948396314472476) 2025-07-20 15:00:44 UTC 31.8K followers, XXX engagements


"🔬✨ Put your #dermatology expertise to the test with Dermatology Times interactive weekly quiz series This week well focus on highlights from our July print edition. #SpotTest #DermTwitter"  
![@DermTimesNow Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::55642575.png) [@DermTimesNow](/creator/x/DermTimesNow) on [X](/post/tweet/1947341547806056687) 2025-07-21 17:02:59 UTC 31.8K followers, XXX engagements


"📰 A global expert consensus team has defined skin quality using X key categories: firmness surface evenness tone evenness and glow. This universal clinical framework can guide personalized #aesthetics care and treatment planning. #DermTwitter"  
![@DermTimesNow Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::55642575.png) [@DermTimesNow](/creator/x/DermTimesNow) on [X](/post/tweet/1946918248861082084) 2025-07-20 13:00:57 UTC 31.8K followers, XXX engagements


"📈 A global survey reveals major gaps between atopic dermatitis treatment guidelines and real-world practices in pregnant and breastfeeding patients. #AD #AtopicDermatitis #DermTwitter"  
![@DermTimesNow Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::55642575.png) [@DermTimesNow](/creator/x/DermTimesNow) on [X](/post/tweet/1947734712048361888) 2025-07-22 19:05:17 UTC 31.8K followers, XXX engagements


"📖 A new systematic review reveals significant diagnostic gaps in the evaluation of hair and scalp disorders in patients with skin of color with XX% of individuals initially misdiagnosed often delaying appropriate treatment"  
![@DermTimesNow Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::55642575.png) [@DermTimesNow](/creator/x/DermTimesNow) on [X](/post/tweet/1945166597603082391) 2025-07-15 17:00:30 UTC 31.8K followers, XXX engagements


"🌟 🔆 July is UV Safety Awareness Month Join Dermatology Times as we raise awareness about the dangers of UV radiation and the importance of sun safety. #DermTwitter #UVSafetyAwarenessMonth"  
![@DermTimesNow Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::55642575.png) [@DermTimesNow](/creator/x/DermTimesNow) on [X](/post/tweet/1946555624839385378) 2025-07-19 13:00:00 UTC 31.8K followers, XXX engagements


"🗓 Review our recap of news from last week including the launch of deuruxolitinib for alopecia areata Treg cel impairment in vitiligo the top aesthetic innovations of this month and more. #TheWeeklyRoundup #DermTwitter"  
![@DermTimesNow Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::55642575.png) [@DermTimesNow](/creator/x/DermTimesNow) on [X](/post/tweet/1947401947763343483) 2025-07-21 21:02:59 UTC 31.8K followers, XXX engagements


"📰 From stress relief to advocacy art became a powerful tool in #dermatology for Mitchell Hanson fostering dialogue on identity equity and patient stories. #DermTwitter"  
![@DermTimesNow Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::55642575.png) [@DermTimesNow](/creator/x/DermTimesNow) on [X](/post/tweet/1947040441347490231) 2025-07-20 21:06:30 UTC 31.8K followers, XXX engagements


"🌟🗓 Explore the top X articles from Dermatology Times from the past week including insights on the latest clinical trials therapeutic updates and more. #Top5"  
![@DermTimesNow Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::55642575.png) [@DermTimesNow](/creator/x/DermTimesNow) on [X](/post/tweet/1945591769392910448) 2025-07-16 21:09:59 UTC 31.8K followers, XXX engagements


"Via real-world patient case discussions gain insights into how dermatology clinicians tailor treatment plans for diverse atopic dermatitis patients:"  
![@DermTimesNow Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::55642575.png) [@DermTimesNow](/creator/x/DermTimesNow) on [X](/post/tweet/1946706814378156440) 2025-07-19 23:00:47 UTC 31.8K followers, XXX engagements


"In a recent Dermatology Times Case-Based Roundtable Gaurav Singh MD MPH spotlighted the transformative impact of gene expression profile testing in personalizing skin cancer care"  
![@DermTimesNow Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::55642575.png) [@DermTimesNow](/creator/x/DermTimesNow) on [X](/post/tweet/1945136415047614746) 2025-07-15 15:00:34 UTC 31.8K followers, XXX engagements


"📰 From quick relief with steroid injections and incision & drainage to lasting control via deroofing excision and lasers tailored #HS treatments improve symptoms and quality of life for patients with this chronic disease. #DermTwitter"  
![@DermTimesNow Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::55642575.png) [@DermTimesNow](/creator/x/DermTimesNow) on [X](/post/tweet/1947311601452724566) 2025-07-21 15:03:59 UTC 31.8K followers, XXX engagements


"❗Turn Therapeutics has begun the first randomized double-blind vehicle-controlled clinical trial of GX-03 a topical IL-36 inhibitor for moderate to severe #AD. #AtopicDermatitis #DermTwitter"  
![@DermTimesNow Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::55642575.png) [@DermTimesNow](/creator/x/DermTimesNow) on [X](/post/tweet/1945561571175940500) 2025-07-16 19:10:00 UTC 31.8K followers, XXX engagements


"☎ After a harsh non-compete uprooted her career Amy Snow PA-C turned adversity into impact and founded Project Happy Face a mobile clinic delivering free dermatology care to underserved Oregon communities. #DermDispatch #DermTwitter"  
![@DermTimesNow Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::55642575.png) [@DermTimesNow](/creator/x/DermTimesNow) on [X](/post/tweet/1946315066220933526) 2025-07-18 21:04:07 UTC 31.8K followers, XXX engagements


"📚 A recent study demonstrated that combining AI-derived histopathological features with traditional dermatopathologist assessments significantly improves the early identification of high-risk cutaneous squamous cell carcinoma"  
![@DermTimesNow Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::55642575.png) [@DermTimesNow](/creator/x/DermTimesNow) on [X](/post/tweet/1944049286347424000) 2025-07-12 15:00:43 UTC 31.8K followers, XXX engagements


"A recent roundtable discussion sheds some light on a novel pathway under investigation in atopic dermatitis. Hear clinical perspectives from dermatology experts. #ad Learn More:"  
![@DermTimesNow Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::55642575.png) [@DermTimesNow](/creator/x/DermTimesNow) on [X](/post/tweet/1942765668903862477) 2025-07-09 02:00:04 UTC 31.8K followers, XXX engagements


"✍📰 Test your knowledge of key words and terms associated with Dermatology Times news from the previous week"  
![@DermTimesNow Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::55642575.png) [@DermTimesNow](/creator/x/DermTimesNow) on [X](/post/tweet/1943415052742041817) 2025-07-10 21:00:30 UTC 31.8K followers, XXX engagements


"❗Yesterday Bristol Myers Squibbs sNDA for #deucravacitinib (#Sotyktu) in psoriatic arthritis was accepted by the FDA with a March 2026 PDUFA date. #Psoriasis #DermTwitter #PsA"  
![@DermTimesNow Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::55642575.png) [@DermTimesNow](/creator/x/DermTimesNow) on [X](/post/tweet/1947704558819356935) 2025-07-22 17:05:28 UTC 31.8K followers, XXX engagements


"📰 New data shows #trifarotene XXXXX% improves both #acne and its #sequelae offering hope for adults and skin of color patients. #DermTwitter"  
![@DermTimesNow Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::55642575.png) [@DermTimesNow](/creator/x/DermTimesNow) on [X](/post/tweet/1946616213955612705) 2025-07-19 17:00:46 UTC 31.8K followers, XXX engagements


"☎ Frustrated by rushed visits and rising costs Jacki Kment PA-C MPAS DFAAPA launched a direct pay dermatology clinic in Nebraska offering longer visits transparent pricing and accessible care for uninsured patients. #DermTwitter"  
![@DermTimesNow Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::55642575.png) [@DermTimesNow](/creator/x/DermTimesNow) on [X](/post/tweet/1946978668284183005) 2025-07-20 17:01:02 UTC 31.8K followers, XXX engagements